|
 Italian guidelines for diagnosis, prevention, and treatment of invasive fungal infections in solid organ transplant recipients. |
|
Grossi PA, Gasperina DD, Barchiesi F, Biancofiore G, Carafiello G, De Gasperi A, Sganga G, Menichetti F, Montagna MT, Pea F, Venditti M, Viale P, Viscoli C, Nanni Costa A.
Transplant Proc. 2011;43(6):2463-71.
|
|
|
|
| |
European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update. |
|
Maertens J, Marchetti O, Herbrecht R, Cornely OA, Flückiger U, Frêre P, Gachot B, Heinz WJ, Lass-Flörl C, Ribaud P, Thiebaut A, Cordonnier C; Third European Conference on Infections in Leukemia.
Bone Marrow Transplant. 2011;46(5):709-18.
|
|
|
|
| |
Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. |
|
Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TF, Edwards JE Jr, Filler SG, Fisher JF, Kullberg BJ, Ostrosky-Zeichner L, Reboli AC, Rex JH, Walsh TJ, Sobel JD; Infectious Diseases Society of America.
Clin Infect Dis. 2009 Mar 1;48(5):503-35
|
|
|
|
| |
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America |
|
Mermel LA, Allon M, Bouza E,Craven DE, Flynn P, O’Grady NP,Raad II, Rijnders BJ, Sherertz RJ,Warren DK
|
|
|
|
| |
CLSI/NCCLS Document M44-A2, September 2009 |
|
Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts;
Approved Guideline— Second Edition
|
|
|
|
| |
CLSI/NCCLS Document M44-S3, September 2009 |
|
Zone Diameter Interpretive Standards, Corresponding Minimal Inhibitory Concentration (MIC) Interpretive Breakpoints, and Quality Control Limits for Antifungal Disk Diffusion Susceptibility Testing of Yeasts;
Informational Supplement
|
|
|
|
| |
CLSI/NCCLS Document M51-P, June 2009 |
|
Method for Antifungal Disk Diffusion Susceptibility Testing of Filamentous Fungi;
Proposed Guideline
|
|
|
|
| |
CLSI/NCCLS Document M51-S1 (Proposed), June 2009 |
|
Performance Standards for Antifungal Disk Diffusion Susceptibility Testing of Filamentous Fungi;
Informational Supplement
|
|
|
|
| |
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. |
|
De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr KA, Muñoz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T, Bennett JE; European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.
Clin Infect Dis. 2008 Jun 15;46(12):1813-21
|
|
|
|
| |
CLSI/NCCLS Document M27-A3, 2008 |
|
Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts;
Approved Standard—Third Edition
|
|
|
|
| |
CLSI/NCCLS Document M27-S3, 2008 |
|
Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts;
Third Informational Supplement
|
|
|
|
| |
CLSI/NCCLS Document M38-A2, 2008 |
|
Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi;
Approved Standard—Second Edition
|
|
|
|
| |
EUCAST Definitive Document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts. |
|
Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committeefor Antimicrobial Susceptibility Testing (EUCAST).
Clin Microbiol Infect. 2008;14(4):398-405.
|
|
|
|
| |
EUCAST DEFINITIVE DOCUMENT E.DEF 9.1: Method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia forming moulds. |
|
Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST); July 2008
|
|
|
|
| |
Clinical Practice Guidelines for the Management of Patients with Histoplasmosis: 2007 Update by the Infectious Diseases Society of America |
|
L. Joseph Wheat, Alison G. Freifeld, Martin B. Kleiman, John W. Baddley, David S. McKinsey, James E. Loyd, and Carol A. Kauffman
Clinical Infectious Diseases 2007;45:807-25
|
|
|
|
| |
|
|
|